Cano Health, Inc. (NYSE: CANO-WT) Stock Competitors & Peer Comparison
See CANO-WT's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CANO-WT and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CANO-WT | $0.01 | -37.24% | 19.3M | N/A | N/A | N/A |
| HCA | $401.46 | -1.89% | 87.7B | 13.98 | $28.96 | +0.74% |
| THC | $260.11 | -1.28% | 21.3B | 15.37 | $17.24 | N/A |
| FMS | $22.51 | +0.16% | 12.2B | 8.52 | $2.66 | +3.81% |
| EHC | $121.08 | -1.24% | 12.1B | 20.85 | $5.84 | +0.62% |
| DVA | $181.48 | -0.10% | 11.8B | 14.37 | $12.80 | N/A |
| UHS | $171.12 | +1.13% | 10.3B | 7.53 | $22.54 | +0.47% |
| ENSG | $171.56 | -0.31% | 10B | 24.75 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $521.66 | -0.53% | 6.8B | 24.06 | $21.61 | +0.48% |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
CANO-WT vs HCA Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, HCA has a market cap of 87.7B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while HCA trades at $401.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas HCA's P/E ratio is 13.98. In terms of profitability, CANO-WT's ROE is -1.49%, compared to HCA's ROE of -1.13%. Regarding short-term risk, CANO-WT is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
CANO-WT vs THC Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, THC has a market cap of 21.3B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while THC trades at $260.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas THC's P/E ratio is 15.37. In terms of profitability, CANO-WT's ROE is -1.49%, compared to THC's ROE of +0.51%. Regarding short-term risk, CANO-WT is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
CANO-WT vs FMS Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while FMS trades at $22.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas FMS's P/E ratio is 8.52. In terms of profitability, CANO-WT's ROE is -1.49%, compared to FMS's ROE of +0.07%. Regarding short-term risk, CANO-WT is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
CANO-WT vs EHC Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while EHC trades at $121.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas EHC's P/E ratio is 20.85. In terms of profitability, CANO-WT's ROE is -1.49%, compared to EHC's ROE of +0.25%. Regarding short-term risk, CANO-WT is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
CANO-WT vs DVA Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, DVA has a market cap of 11.8B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while DVA trades at $181.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas DVA's P/E ratio is 14.37. In terms of profitability, CANO-WT's ROE is -1.49%, compared to DVA's ROE of -1.24%. Regarding short-term risk, CANO-WT is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
CANO-WT vs UHS Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while UHS trades at $171.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas UHS's P/E ratio is 7.53. In terms of profitability, CANO-WT's ROE is -1.49%, compared to UHS's ROE of +0.21%. Regarding short-term risk, CANO-WT is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
CANO-WT vs ENSG Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while ENSG trades at $171.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas ENSG's P/E ratio is 24.75. In terms of profitability, CANO-WT's ROE is -1.49%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, CANO-WT is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
CANO-WT vs OSH Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas OSH's P/E ratio is -17.65. In terms of profitability, CANO-WT's ROE is -1.49%, compared to OSH's ROE of +4.64%. Regarding short-term risk, CANO-WT is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
CANO-WT vs CHE Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while CHE trades at $521.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas CHE's P/E ratio is 24.06. In terms of profitability, CANO-WT's ROE is -1.49%, compared to CHE's ROE of +0.29%. Regarding short-term risk, CANO-WT is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
CANO-WT vs PACS Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, PACS has a market cap of 6.7B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while PACS trades at $43.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas PACS's P/E ratio is 22.49. In terms of profitability, CANO-WT's ROE is -1.49%, compared to PACS's ROE of +0.27%. Regarding short-term risk, CANO-WT is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check PACS's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
CANO-WT vs HIMS Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while HIMS trades at $27.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas HIMS's P/E ratio is -43.30. In terms of profitability, CANO-WT's ROE is -1.49%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, CANO-WT is more volatile compared to HIMS. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
CANO-WT vs LHCG Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas LHCG's P/E ratio is 82.83. In terms of profitability, CANO-WT's ROE is -1.49%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, CANO-WT is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
CANO-WT vs LFST Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while LFST trades at $12.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas LFST's P/E ratio is 95.88. In terms of profitability, CANO-WT's ROE is -1.49%, compared to LFST's ROE of +0.03%. Regarding short-term risk, CANO-WT is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
CANO-WT vs CON Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while CON trades at $34.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas CON's P/E ratio is 21.68. In terms of profitability, CANO-WT's ROE is -1.49%, compared to CON's ROE of +0.47%. Regarding short-term risk, CANO-WT is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
CANO-WT vs OPCH Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while OPCH trades at $23.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas OPCH's P/E ratio is 14.08. In terms of profitability, CANO-WT's ROE is -1.49%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, CANO-WT is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
CANO-WT vs NHC Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, NHC has a market cap of 3.4B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while NHC trades at $221.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas NHC's P/E ratio is 27.82. In terms of profitability, CANO-WT's ROE is -1.49%, compared to NHC's ROE of +0.13%. Regarding short-term risk, CANO-WT is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
CANO-WT vs AMED Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AMED's P/E ratio is 39.30. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AMED's ROE of +0.11%. Regarding short-term risk, CANO-WT is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
CANO-WT vs AVAH Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AVAH has a market cap of 3B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AVAH trades at $13.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AVAH's P/E ratio is 19.97. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, CANO-WT is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
CANO-WT vs BKD Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, BKD has a market cap of 2.8B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while BKD trades at $12.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas BKD's P/E ratio is -20.29. In terms of profitability, CANO-WT's ROE is -1.49%, compared to BKD's ROE of +4.06%. Regarding short-term risk, CANO-WT is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
CANO-WT vs ACHC Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while ACHC trades at $27.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas ACHC's P/E ratio is 14.14. In terms of profitability, CANO-WT's ROE is -1.49%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, CANO-WT is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check ACHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
CANO-WT vs GRDN Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while GRDN trades at $41.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas GRDN's P/E ratio is 35.76. In terms of profitability, CANO-WT's ROE is -1.49%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, CANO-WT is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
CANO-WT vs MD Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while MD trades at $26.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas MD's P/E ratio is 12.07. In terms of profitability, CANO-WT's ROE is -1.49%, compared to MD's ROE of +0.20%. Regarding short-term risk, CANO-WT is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
CANO-WT vs ADUS Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while ADUS trades at $119.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas ADUS's P/E ratio is 17.78. In terms of profitability, CANO-WT's ROE is -1.49%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, CANO-WT is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
CANO-WT vs SEM Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas SEM's P/E ratio is 15.43. In terms of profitability, CANO-WT's ROE is -1.49%, compared to SEM's ROE of +0.08%. Regarding short-term risk, CANO-WT is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
CANO-WT vs ASTH Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while ASTH trades at $37.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas ASTH's P/E ratio is 46.35. In terms of profitability, CANO-WT's ROE is -1.49%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, CANO-WT is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
CANO-WT vs SGRY Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while SGRY trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas SGRY's P/E ratio is 36.56. In terms of profitability, CANO-WT's ROE is -1.49%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, CANO-WT is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
CANO-WT vs AMEH Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AMEH's P/E ratio is 39.25. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, CANO-WT is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AMEH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
CANO-WT vs SNDA Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while SNDA trades at $39.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas SNDA's P/E ratio is -6.09. In terms of profitability, CANO-WT's ROE is -1.49%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, CANO-WT is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check SNDA's competition here
Ardent Health Inc. (NYSE: ARDT)
CANO-WT vs ARDT Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while ARDT trades at $10.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas ARDT's P/E ratio is 8.80. In terms of profitability, CANO-WT's ROE is -1.49%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, CANO-WT is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
CANO-WT vs HCSG Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while HCSG trades at $21.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas HCSG's P/E ratio is 17.46. In terms of profitability, CANO-WT's ROE is -1.49%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, CANO-WT is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
CANO-WT vs AGL Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AGL trades at $90.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AGL's P/E ratio is -5.74. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AGL's ROE of -1.19%. Regarding short-term risk, CANO-WT is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
CANO-WT vs INNV Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while INNV trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas INNV's P/E ratio is -119.44. In terms of profitability, CANO-WT's ROE is -1.49%, compared to INNV's ROE of -0.09%. Regarding short-term risk, CANO-WT is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check INNV's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
CANO-WT vs NUTX Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while NUTX trades at $191.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas NUTX's P/E ratio is 7.65. In terms of profitability, CANO-WT's ROE is -1.49%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, CANO-WT is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check NUTX's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
CANO-WT vs PNTG Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while PNTG trades at $39.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas PNTG's P/E ratio is 28.79. In terms of profitability, CANO-WT's ROE is -1.49%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, CANO-WT is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
CANO-WT vs AMN Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AMN trades at $33.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AMN's P/E ratio is 11.23. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AMN's ROE of +0.15%. Regarding short-term risk, CANO-WT is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
CANO-WT vs BKDT Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas BKDT's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, CANO-WT is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
CANO-WT vs USPH Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while USPH trades at $79.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas USPH's P/E ratio is 31.24. In terms of profitability, CANO-WT's ROE is -1.49%, compared to USPH's ROE of -0.01%. Regarding short-term risk, CANO-WT is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
CANO-WT vs TALK Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas TALK's P/E ratio is 774.34. In terms of profitability, CANO-WT's ROE is -1.49%, compared to TALK's ROE of +0.00%. Regarding short-term risk, CANO-WT is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
CANO-WT vs GMRS Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, GMRS has a market cap of 727M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while GMRS trades at $13.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas GMRS's P/E ratio is 5.98. In terms of profitability, CANO-WT's ROE is -1.49%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, CANO-WT is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
CANO-WT vs EHAB Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas EHAB's P/E ratio is -197.14. In terms of profitability, CANO-WT's ROE is -1.49%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, CANO-WT is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
CANO-WT vs STLN Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, STLN has a market cap of 592.9M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while STLN trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas STLN's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to STLN's ROE of +2.10%. Regarding short-term risk, CANO-WT is more volatile compared to STLN. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
CANO-WT vs TOI Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas TOI's P/E ratio is -14.25. In terms of profitability, CANO-WT's ROE is -1.49%, compared to TOI's ROE of +2.10%. Regarding short-term risk, CANO-WT is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
CANO-WT vs SRTA Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, SRTA has a market cap of 460.3M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while SRTA trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas SRTA's P/E ratio is -25.08. In terms of profitability, CANO-WT's ROE is -1.49%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, CANO-WT is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
CANO-WT vs MCTA Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas MCTA's P/E ratio is 419.36. In terms of profitability, CANO-WT's ROE is -1.49%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, CANO-WT is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
CANO-WT vs CYH Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, CYH has a market cap of 407.5M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while CYH trades at $2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas CYH's P/E ratio is 3.96. In terms of profitability, CANO-WT's ROE is -1.49%, compared to CYH's ROE of +0.21%. Regarding short-term risk, CANO-WT is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
CANO-WT vs AUNA Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AUNA has a market cap of 390.8M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AUNA trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AUNA's P/E ratio is 4.76. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, CANO-WT is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
CANO-WT vs VMD Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, VMD has a market cap of 345.8M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while VMD trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas VMD's P/E ratio is 25.22. In terms of profitability, CANO-WT's ROE is -1.49%, compared to VMD's ROE of +0.10%. Regarding short-term risk, CANO-WT is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
CANO-WT vs CSU Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas CSU's P/E ratio is 0.67. In terms of profitability, CANO-WT's ROE is -1.49%, compared to CSU's ROE of -0.33%. Regarding short-term risk, CANO-WT is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
CANO-WT vs AIRS Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AIRS has a market cap of 197.2M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AIRS trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AIRS's P/E ratio is -93.17. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, CANO-WT is more volatile compared to AIRS. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
CANO-WT vs JYNT Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, JYNT has a market cap of 118.6M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while JYNT trades at $8.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas JYNT's P/E ratio is 83.20. In terms of profitability, CANO-WT's ROE is -1.49%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, CANO-WT is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
CANO-WT vs FVE Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas FVE's P/E ratio is -5.64. In terms of profitability, CANO-WT's ROE is -1.49%, compared to FVE's ROE of -0.15%. Regarding short-term risk, CANO-WT is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
CANO-WT vs KDLYW Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas KDLYW's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, CANO-WT is more volatile compared to KDLYW. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
CANO-WT vs PARK Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, PARK has a market cap of 92.2M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while PARK trades at $20.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas PARK's P/E ratio is 27.61. In terms of profitability, CANO-WT's ROE is -1.49%, compared to PARK's ROE of -0.18%. Regarding short-term risk, CANO-WT is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
CANO-WT vs BTMD Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, BTMD has a market cap of 68.1M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while BTMD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas BTMD's P/E ratio is 14.05. In terms of profitability, CANO-WT's ROE is -1.49%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, CANO-WT is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
CANO-WT vs ALR Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas ALR's P/E ratio is -1.11. In terms of profitability, CANO-WT's ROE is -1.49%, compared to ALR's ROE of -0.15%. Regarding short-term risk, CANO-WT is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
CANO-WT vs DCGO Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, DCGO has a market cap of 39.8M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while DCGO trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas DCGO's P/E ratio is -0.22. In terms of profitability, CANO-WT's ROE is -1.49%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, CANO-WT is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
CANO-WT vs CCEL Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, CCEL has a market cap of 34.5M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while CCEL trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas CCEL's P/E ratio is -14.27. In terms of profitability, CANO-WT's ROE is -1.49%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, CANO-WT is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
CANO-WT vs IMAC Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas IMAC's P/E ratio is -2.27. In terms of profitability, CANO-WT's ROE is -1.49%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, CANO-WT is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
CANO-WT vs PIII Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, PIII has a market cap of 30.6M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while PIII trades at $8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas PIII's P/E ratio is -0.28. In terms of profitability, CANO-WT's ROE is -1.49%, compared to PIII's ROE of +1.61%. Regarding short-term risk, CANO-WT is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
CANO-WT vs EUDA Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, EUDA has a market cap of 25.2M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while EUDA trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas EUDA's P/E ratio is -25.45. In terms of profitability, CANO-WT's ROE is -1.49%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, CANO-WT is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check EUDA's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
CANO-WT vs PIIIW Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, PIIIW has a market cap of 24.5M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas PIIIW's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, CANO-WT is more volatile compared to PIIIW. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check PIIIW's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
CANO-WT vs AIH Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AIH's P/E ratio is -2.78. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AIH's ROE of +1.16%. Regarding short-term risk, CANO-WT is more volatile compared to AIH. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
CANO-WT vs CANO Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas CANO's P/E ratio is -0.01. In terms of profitability, CANO-WT's ROE is -1.49%, compared to CANO's ROE of -1.49%. Regarding short-term risk, CANO-WT is more volatile compared to CANO. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
CANO-WT vs FPCG Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas FPCG's P/E ratio is 0.09. In terms of profitability, CANO-WT's ROE is -1.49%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, CANO-WT is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
CANO-WT vs FTRP Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas FTRP's P/E ratio is -1.22. In terms of profitability, CANO-WT's ROE is -1.49%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, CANO-WT is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
CANO-WT vs AMS Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AMS's P/E ratio is -5.66. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AMS's ROE of -0.07%. Regarding short-term risk, CANO-WT is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
CANO-WT vs BMGL Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, BMGL has a market cap of 7.6M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while BMGL trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas BMGL's P/E ratio is -0.91. In terms of profitability, CANO-WT's ROE is -1.49%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, CANO-WT is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
CANO-WT vs AIDX Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AIDX has a market cap of 7.2M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AIDX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AIDX's P/E ratio is -1.12. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, CANO-WT is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
CANO-WT vs MODV Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas MODV's P/E ratio is -0.06. In terms of profitability, CANO-WT's ROE is -1.49%, compared to MODV's ROE of +1.36%. Regarding short-term risk, CANO-WT is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
CANO-WT vs GBNH Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas GBNH's P/E ratio is -0.06. In terms of profitability, CANO-WT's ROE is -1.49%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, CANO-WT is more volatile compared to GBNH. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check GBNH's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
CANO-WT vs STLNW Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, STLNW has a market cap of 5.3M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas STLNW's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, CANO-WT is more volatile compared to STLNW. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check STLNW's competition here
Regional Health Properties, Inc. (AMEX: RHE)
CANO-WT vs RHE Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas RHE's P/E ratio is -1.79. In terms of profitability, CANO-WT's ROE is -1.49%, compared to RHE's ROE of -1.31%. Regarding short-term risk, CANO-WT is more volatile compared to RHE. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
CANO-WT vs RHE-PA Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, CANO-WT's ROE is -1.49%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, CANO-WT is more volatile compared to RHE-PA. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
CANO-WT vs TOIIW Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, CANO-WT's ROE is -1.49%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, CANO-WT is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
CANO-WT vs IMACW Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas IMACW's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, CANO-WT is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for CANO-WT.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
CANO-WT vs EDVA Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, EDVA has a market cap of 1.7M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while EDVA trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas EDVA's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to EDVA's ROE of N/A. Regarding short-term risk, CANO-WT is more volatile compared to EDVA. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
CANO-WT vs EUDAW Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, CANO-WT's ROE is -1.49%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, CANO-WT is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for CANO-WT.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
CANO-WT vs CCM Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, CCM has a market cap of 681.5K. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while CCM trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas CCM's P/E ratio is -0.31. In terms of profitability, CANO-WT's ROE is -1.49%, compared to CCM's ROE of +0.06%. Regarding short-term risk, CANO-WT is more volatile compared to CCM. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
CANO-WT vs NIVF Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while NIVF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas NIVF's P/E ratio is 0.56. In terms of profitability, CANO-WT's ROE is -1.49%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, CANO-WT is more volatile compared to NIVF. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
CANO-WT vs NIVFW Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, NIVFW has a market cap of 45.7K. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, CANO-WT's ROE is -1.49%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, CANO-WT is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
CANO-WT vs MNDR Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, MNDR has a market cap of 34.9K. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while MNDR trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas MNDR's P/E ratio is -0.04. In terms of profitability, CANO-WT's ROE is -1.49%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, CANO-WT is more volatile compared to MNDR. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
CANO-WT vs TALKW Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas TALKW's P/E ratio is 0.00. In terms of profitability, CANO-WT's ROE is -1.49%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, CANO-WT is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for CANO-WT.Check TALKW's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
CANO-WT vs DVCR Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas DVCR's P/E ratio is 28.34. In terms of profitability, CANO-WT's ROE is -1.49%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, CANO-WT is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check DVCR's competition here
New Frontier Health Corporation (NYSE: NFH)
CANO-WT vs NFH Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, NFH has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas NFH's P/E ratio is -19.75. In terms of profitability, CANO-WT's ROE is -1.49%, compared to NFH's ROE of -0.06%. Regarding short-term risk, CANO-WT is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check NFH's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
CANO-WT vs TVTY Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas TVTY's P/E ratio is 19.06. In terms of profitability, CANO-WT's ROE is -1.49%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, CANO-WT is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check TVTY's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
CANO-WT vs ATIP-WT Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, CANO-WT is more volatile compared to ATIP-WT. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check ATIP-WT's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
CANO-WT vs TLMDW Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas TLMDW's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, CANO-WT is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check TLMDW's competition here
Hanger, Inc. (NYSE: HNGR)
CANO-WT vs HNGR Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas HNGR's P/E ratio is 19.71. In terms of profitability, CANO-WT's ROE is -1.49%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, CANO-WT is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check HNGR's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
CANO-WT vs SLHGP Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, CANO-WT's ROE is -1.49%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, CANO-WT is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check SLHGP's competition here
Kindred Healthcare, Inc. (NYSE: KND)
CANO-WT vs KND Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, KND has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas KND's P/E ratio is -1.14. In terms of profitability, CANO-WT's ROE is -1.49%, compared to KND's ROE of -0.53%. Regarding short-term risk, CANO-WT is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check KND's competition here
DocGo Inc. (NASDAQ: DCGOW)
CANO-WT vs DCGOW Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas DCGOW's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, CANO-WT is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check DCGOW's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
CANO-WT vs SLHG Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas SLHG's P/E ratio is -1.48. In terms of profitability, CANO-WT's ROE is -1.49%, compared to SLHG's ROE of N/A. Regarding short-term risk, CANO-WT is more volatile compared to SLHG. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
CANO-WT vs AFAM Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas AFAM's P/E ratio is N/A. In terms of profitability, CANO-WT's ROE is -1.49%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, CANO-WT is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
CANO-WT vs TLMD Comparison September 2026
Cano Health, Inc. (NYSE: CANO-WT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO-WT stands at 19.3M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, CANO-WT is priced at $0.01 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO-WT currently has a P/E ratio of N/A, whereas TLMD's P/E ratio is -1.60. In terms of profitability, CANO-WT's ROE is -1.49%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, CANO-WT is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for CANO-WT.Check TLMD's competition here